Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Qingyang Pharmaceutical is a prominent Chinese pharmaceutical enterprise specializing in the research, development, and large-scale production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company is globally recognized as a leading manufacturer of the Vitamin B12 series, including Cyanocobalamin, Mecobalamin, and Adenosylcobalamin. Beyond its core nutritional portfolio, the company produces a variety of treatments for cardiovascular diseases, infections, and gastrointestinal disorders. Operating with multiple GMP-certified facilities, Chongqing Qingyang Pharmaceutical serves as a critical supplier to both domestic Chinese markets and international pharmaceutical distributors. Its business model integrates chemical synthesis with advanced fermentation technologies to maintain high-purity standards for its specialized API catalog.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Qingyang Pharmaceutical.